Illumina Inc said on Monday it would buy cancer screening startup Grail Inc in a cash-and-stock deal worth $8 billion, buying out investors including Jeff Bezos and snatching back a business it spun ...

Illumina Inc. and spun-off Grail Inc. defeated allegations the biotechnology company misled shareholders during the ...

"Illumina has inflicted substantial harm on Element, resulting in lost sales, diminished market share, and reduced profits," ...

Shares of Illumina, Inc. (ILMN) rose 6% on Wednesday afternoon after the biotechnology company announced the launch of a new ...

It doesn't matter your age or experience: taking full advantage of the stock market and investing with confidence are common goals for all investors. Luckily, Zacks Premium offers several different ...

Gene sequencing company Illumina Inc is in late talks to buy cancer testing startup Grail Inc, Bloomberg News reported on Wednesday, citing people familiar with the matter.

Illumina Inc. (NASDAQ:ILMN) ranks among the top NASDAQ stocks with low P/E ratios. On September 23, Illumina Inc.

May 6 (Reuters) - A Delaware jury on Friday ordered Illumina Inc ILMN.O to pay more than $333 million to a U.S. unit of Chinese genetic analysis company BGI Genomics ...

Illumina, Inc. (NASDAQ: ILMN) today announced the launch of BioInsight, a new business within Illumina, developed to meet ...

SAN DIEGO--(BUSINESS WIRE)-- Illumina, Inc. (“Illumina”) (NASDAQ: ILMN) has been notified of an unsolicited “mini-tender offer” by TRC Capital Corporation (“TRC”) to purchase up to 500,000 shares of ...

After reporting preliminary sales figures that were south of industry watchers' forecasts, shares in gene-sequencing giant Illumina Corp. toppled this week. Meanwhile, better-than-anticipated sales at ...

Genome sequencing company Illumina Inc ILMN has transformed its business over the years with a handful of acquisitions and new product launches. An acquisition in 2006 was one of the most important in ...